A Prospective Observational Study on Short and Long-Term Outcomes of COVID-19 Patients with Acute Hypoxic Respiratory Failure Treated with High-Flow Nasal Cannula

• Published in: Journal of clinical medicine Vol. 12; no. 4; p. 1249
• Main Authors: Medeiros, Kyle J, Valsecchi, Carlo, Winterton, Dario, Morais, Caio A, Delgado, Eduardo Diaz, Smith, Shaun, Safaee Fakhr, Bijan, Ranjeva, Sylvia, Capriles, Martin, Gaulton, Timothy, Li, Matthew D, Fintelmann, Florian, Tahir, Ismail, Carroll, Ryan, Bittner, Edward A, Hibbert, Kathryn A, Thompson, Boyd Taylor, Hardin, Charles C, Santiago, Roberta Rs, La Vita, Carolyn J, Cereda, Maurizio, Berra, Lorenzo
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 04-02-2023; MDPI
• Subjects: Body mass index; Care and treatment; Clinical medicine; Consent; Coronaviruses; COVID-19; Hemodynamics; Hospitalization; Hypoxia; Intubation; Lung diseases; Medical records; Mortality; Observational studies; Oxygen equipment (Medical care); Oxygen saturation; Palliative care; Patient outcomes; Patients; Pneumonia; Regression analysis; Respiratory failure; Respiratory insufficiency; Severe acute respiratory syndrome coronavirus 2; Success; Variables; Ventilators; United States; United States > US; Massachusetts; COVID-19; critical care; high-flow nasal cannula
• ISSN: 2077-0383; 2077-0383
• DOI: 10.3390/jcm12041249

(1) The use of high-flow nasal cannula (HFNC) combined with frequent respiratory monitoring in patients with acute hypoxic respiratory failure due to COVID-19 has been shown to reduce intubation and mechanical ventilation. (2) This prospective, single-center, observational study included consecutive adult patients with COVID-19 pneumonia treated with a high-flow nasal cannula. Hemodynamic parameters, respiratory rate, inspiratory fraction of oxygen (F
O
), saturation of oxygen (S
O
), and the ratio of oxygen saturation to respiratory rate (ROX) were recorded prior to treatment initiation and every 2 h for 24 h. A 6-month follow-up questionnaire was also conducted. (3) Over the study period, 153 of 187 patients were eligible for HFNC. Of these patients, 80% required intubation and 37% of the intubated patients died in hospital. Male sex (OR = 4.65; 95% CI [1.28; 20.6],
= 0.03) and higher BMI (OR = 2.63; 95% CI [1.14; 6.76],
= 0.03) were associated with an increased risk for new limitations at 6-months after hospital discharge. (4) 20% of patients who received HFNC did not require intubation and were discharged alive from the hospital. Male sex and higher BMI were associated with poor long-term functional outcomes.